|
|
|
| Engineering confidence for cell and gene manufacturing. | 3P innovation partners with cell and gene therapy developers, manufacturers and CDMOs to reduce manufacturing risk, accelerate scale-up and bring transformative therapies to patients faster. Our portfolio of advanced aseptic fill-finish platforms delivers proven, scalable technology, while our custom automation capability provides bespoke systems for complex manufacturing challenges. As a trusted automation engineering partner, we combine platform expertise with specialist engineering capability to deliver reliable, scalable solutions for the next generation of therapies. |
|
|
|
|
By Sachin Bhandari, TrustBridge Compliance | The European Commission and the Pharmaceutical Inspection Co-operation Scheme (PIC/S) consulted on draft Annex 22, Artificial Intelligence. Here's what you should know. | |
|
|
|
|
|
|
|
|
|
| The Advantages Of Off-The-Shelf GMP iPSCs With A DMF | Webinar | Applied StemCell | See how off-the-shelf, GMP-grade iPSC lines with a Drug Master File (DMF) can accelerate cell therapy development, streamline regulatory approval, and reduce time and cost to clinic. |
|
|
| Sensitive Viral Safety Testing For Adventitious Virus Detection | Application Note | By Matthew Fosbrink, Megan Zais, Dylan Barbera, and Jonathan Shaffer, QIAGEN | Examine a modern approach to adventitious virus detection that shows how targeted sequencing can achieve sensitive, comprehensive viral safety testing aligned with ICH MAP, RAP, and HAP expectations. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|